Log in
FREE 15-Day Trial
Intelligent Investor
Intelligent Investor
  1. Home
  2. Research & Advice
  3. Research Tools
  4. Shares
  5. Sierra Rutile Holdings Limited (SRX)
  6. Company Announcements

Sierra Rutile Holdings Limited (ASX: SRX) - Announcements

Current share price for SRX : $0.130 0.01 (8.33%)

ASX company news and announcements for Sierra Rutile Holdings Limited (SRX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Sierra Rutile Holdings Limited (SRX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Sierra Rutile Holdings Limited (SRX), please use our Company Announcements tool to search across all ASX-listed companies.

Intelligent Investor free trial for buy hold sell stock recommendations

Latest company announcements for Sierra Rutile Holdings Limited (SRX)

Search all Announcements
Market Cap ($m) Headline Announcement date/time + Price at ann'ment + Current price + Price
7D Avg		 Gain/Loss
$55 Commitments Test Entity - First Quarter Report 31 Oct 2006 2:33PM $2.960 $0.130 $0.115 fallen by 95.61%
$55 Legal Proceedings - Cross-claims against Dr Gray & CRI 27 Oct 2006 9:59AM $2.880 $0.130 $0.115 fallen by 95.49%
$55 New Clinical Trials 28 Sep 2006 2:05PM $2.350 $0.130 $0.115 fallen by 94.47%
$55 Defamation Proceedings against Non-Executive Directors 27 Sep 2006 2:55PM $2.260 $0.130 $0.115 fallen by 94.25%
$55 Preliminary Final Report 23 Aug 2006 2:36PM $2.300 $0.130 $0.115 fallen by 94.35%
$55 Legal Proceedings & New Chairman 22 Aug 2006 12:45PM $2.250 $0.130 $0.115 fallen by 94.22%
$55 Commitments Test Entity - Fourth Quarter Report 25 Jul 2006 2:09PM $2.300 $0.130 $0.115 fallen by 94.35%
$55 Commitments Test Entity - Third Quarter Report 20 Apr 2006 10:03AM $2.880 $0.130 $0.115 fallen by 95.49%
$55 New Clinical Trials 13 Apr 2006 11:24AM $2.990 $0.130 $0.115 fallen by 95.65%
$55 Half Yearly Report & Half Year Accounts 15 Mar 2006 9:39AM $2.810 $0.130 $0.115 fallen by 95.37%
$55 SIR-Spheres Public & Private Health Fund Reimbursement 9 Mar 2006 5:26PM $2.360 $0.130 $0.115 fallen by 94.49%
$55 Commitments Test Entity - Second Quarter Report 24 Jan 2006 11:44AM $1.990 $0.130 $0.115 fallen by 93.47%
$55 Public Funding approved by Australian Government 22 Dec 2005 3:56PM $1.900 $0.130 $0.115 fallen by 93.16%
$55 Commitments Test Entity - First Quarter Report 24 Oct 2005 9:10AM $2.110 $0.130 $0.115 fallen by 93.84%
$55 Bowel Pancreatic Trials Release 8 Sep 2005 9:06AM $2.250 $0.130 $0.115 fallen by 94.22%
$55 Preliminary Final Report/Annual Report 31 Aug 2005 3:28PM $1.850 $0.130 $0.115 fallen by 92.97%
$55 Response to ASX Price Query 23 Aug 2005 9:22AM $2.100 $0.130 $0.115 fallen by 93.81%
$55 Commitments Test Entity - Fourth Quarter Report 28 Jul 2005 11:13AM $1.800 $0.130 $0.115 fallen by 92.78%
$55 Use of SIR-Spheres in Breast Cancer Patients 19 Apr 2005 11:39AM $1.650 $0.130 $0.115 fallen by 92.12%
$55 Federal Government approves Start Grant 28 Oct 2004 8:30AM $2.820 $0.130 $0.115 fallen by 95.39%
$55 Israeli Approval 25 Oct 2004 10:03AM $2.820 $0.130 $0.115 fallen by 95.39%
$55 Improvement in USA Reimbursement 26 Aug 2004 2:26PM $2.310 $0.130 $0.115 fallen by 94.37%
$55 Clinical Trial Results 10 Aug 2004 10:47AM $2.750 $0.130 $0.115 fallen by 95.27%
$55 New Manufacturing Site 7 Jun 2004 11:02AM $2.860 $0.130 $0.115 fallen by 95.45%
$55 Half Yearly Report & Accounts 24 Feb 2004 2:51PM $3.660 $0.130 $0.115 fallen by 96.45%

726 - 750 of 757 results

Page 30 of 31

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.